Project Overview
Our R&D pipeline follows a robust, stepwise approach to ensure both scientific credibility and practical usability.
• Concept and Biomarker Selection: Identifying and validating the most reliable biomarkers.
• Prototype Development: Designing and testing lateral flow assays and ELISA kits.
• Validation: Conducting rigorous sensitivity and specificity testing in both human and veterinary samples.
• Clinical Trials: Partnering with hospitals, primary health centers, and veterinary clinics for real-world validation.
• Regulatory Compliance: Ensuring adherence to CDSCO and ISO 13485 standards.
• Commercialization: Preparing for pilot-scale manufacturing, packaging, distribution, and post-market monitoring.
By combining artificial intelligence with biomarker science, BridgeInDx creates diagnostic solutions that are accurate, scalable, and accessible for all.
